HI EISAI PHARMACEUTICAL INC

Company Type: Trading Company (Distributor)

Company Introduction:

HI EISAI PHARMACEUTICAL INC, officially known as Eisai (Philippines), Inc., is the Philippine subsidiary of Eisai Co., Ltd., a leading global research-based pharmaceutical company headquartered in Japan.

While Eisai Co., Ltd. globally operates as a major pharmaceutical manufacturer, the primary function of its Philippine entity, HI EISAI PHARMACEUTICAL INC, is that of a trading company. It focuses on the importation, marketing, sales, and distribution of Eisai's innovative pharmaceutical products throughout the Philippines.

The company is committed to addressing unmet medical needs and enhancing the health and well-being of patients in the country. It specializes in therapeutic areas such as oncology, neurology, and gastroenterology. HI EISAI PHARMACEUTICAL INC ensures the availability of high-quality and effective pharmaceutical products, contributing to the local healthcare system through ethical business practices and patient-centric initiatives. It serves as the local channel responsible for bringing Eisai's global pharmaceutical advancements to the Filipino market.

HI EISAI PHARMACEUTICAL INC in the Philippines manufactures or sells the following products:

Lenvima (Lenvatinib)

Fycompa (Perampanel)

Halaven (Eribulin)

Pariet (Rabeprazole)

Aricept (Donepezil)